Better Therapeutics, Inc.
BTTX · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $26 | $110 | $76 | $236 |
| - Cash | $16 | $41 | $0 | $1 |
| + Debt | $15 | $10 | $1 | $5 |
| Enterprise Value | $25 | $79 | $76 | $240 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | -100% | -55.6% | – |
| Gross Profit | -$3 | -$2 | -$1 | -$1 |
| % Margin | – | – | -8,425% | -4,888.9% |
| EBITDA | -$38 | -$39 | -$6 | -$6 |
| % Margin | – | – | -75,737.5% | -31,672.2% |
| Net Income | -$40 | -$40 | -$6 | -$6 |
| % Margin | – | – | -79,837.5% | -32,194.4% |
| EPS Diluted | -1.69 | -1.71 | -1.04 | -0.25 |
| % Growth | 1.2% | -64.4% | -316% | – |
| Operating Cash Flow | -$29 | -$31 | -$6 | -$6 |
| Capital Expenditures | -$1 | -$1 | -$2 | -$3 |
| Free Cash Flow | -$30 | -$32 | -$8 | -$9 |